SCHEMBL3575327

SCHEMBL3575327

O=C(O)Cc1cc(OCc2cccc(C(F)(F)F)c2)cc(-c2ccc(C(F)(F)F)cc2)c1

nearest known ligand 0.61

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
PPARD Q03181 5/20 0.61
PPARA Q07869 2/20 0.61
FFAR1 O14842 4/20 0.57
NR4A2 P43354 2/20 0.57
FFAR4 Q5NUL3 1/20 0.57
MRGPRX4 Q96LA9 2/20 0.54
RXRA P19793 3/20 0.54
RXRB P28702 2/20 0.54
RXRG P48443 2/20 0.54
NR1H2 P55055 1/20 0.53
NR1H3 Q13133 1/20 0.53
MAOB P27338 2/20 0.53
PSEN1 P49768 1/20 0.53
PSEN2 P49810 1/20 0.53
APH1B Q8WW43 1/20 0.53
NCSTN Q92542 1/20 0.53
APH1A Q96BI3 1/20 0.53
PSENEN Q9NZ42 1/20 0.53

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL478042 0.92 PPARD (0.65) PPARDPPARAFFAR1RXRARXRB
SCHEMBL3572956 0.90 PPARD (0.57) PPARDPPARAFFAR1MRGPRX4RXRA
SCHEMBL3574038 0.89 PPARD (0.67) PPARDPPARARXRARXRBRXRG
SCHEMBL3576699 0.87 PTPN1 (0.61) PPARDPPARAFFAR1NR4A2FFAR4
SCHEMBL13460803 0.86 NR4A2 (0.66) PPARDPPARAFFAR1NR4A2FFAR4
SCHEMBL3573491 0.85 PPARD (0.62) PPARDPPARARXRARXRBRXRG
SCHEMBL3574383 0.84 PPARD (0.63) PPARDPPARARXRARXRBRXRG
SCHEMBL3573400 0.84 PPARD (0.63) PPARDPPARARXRARXRBRXRG
SCHEMBL3569504 0.84 PPARD (0.64) PPARDPPARAFFAR1RXRARXRB
SCHEMBL3570315 0.83 PTPN1 (0.58) PPARDPPARAFFAR1FFAR4RXRA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7825160-B2 such as [5-(4-Fluoro-benzyloxy)-4'-trifluoromethyl-biphenyl-3-yl]-acetic acid, used for the treatment of Alzheimer's disease and for the modulation of gamma -secretase activity CELLZOME LIMITED (GB) 2010-11-02 US claimed
US-20090118289-A1 (Biphenyl) Carboxylic Acids and Derivatives Thereof CELLZOME AG (DE) 2009-05-07 US claimed
EP-1805129-B1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME LTD (GB) 2009-03-18 EP claimed
US-7825160-B2 such as [5-(4-Fluoro-benzyloxy)-4'-trifluoromethyl-biphenyl-3-yl]-acetic acid, used for the treatment of Alzheimer's disease and for the modulation of gamma -secretase activity CELLZOME LIMITED (GB) 2010-11-02 US disclosed
US-20090118289-A1 (Biphenyl) Carboxylic Acids and Derivatives Thereof CELLZOME AG (DE) 2009-05-07 US disclosed
EP-1805129-B1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME LTD (GB) 2009-03-18 EP disclosed
EP-1805129-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2007-07-11 EP disclosed
WO-2006045554-A1 (BIPHENYL) CARBOXYLIC ACIDS AND DERIVATIVES THEREOF CELLZOME AG (DE) 2006-05-04 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090118289-A1 (Biphenyl) Carboxylic Acids and Derivatives Thereof BACE1, BACE2, APP PPARD 455/4885PPARA 327/4885FFAR1 233/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.